African Women Test Anti-HIV Gel in Phase 3 Clinical Trials
Filed in archive Drugs, Vaccines and Therapeutics on February 11, 2006
More than 6,000 women in South Africa has been recruited for the Phase 3 clinical trials of the microbicide gel against AIDS called Carraguard. According to the Population Council:
Carraguard® (formerly known as PC-515) is the Population Council's lead candidate microbicide, a gel whose active pharmaceutical ingredient is made from carrageenan, a substance derived from seaweed. Carrageenan is inexpensive and stable and has been used for hundreds of years as a thickener in foods and as an emulsifier in topical creams and lotions.
Previous in vitro and in vivo trials have shown Carraguard to prevent HIV transmission, by lining the vaginal mucosa, thereby blocking the HIV virus from entering the cells.
This Phase 3 clinical trials are conducted to confirm that Carraguard® Gel can prevent the transmission of HIV when used during vaginal intercourse, and that the gel is safe for vaginal use. The study is expected to be concluded early 2007.
Source: Womens E-news, Photo: PopCouncil
Tags: HIV microbicide biotech phase trials phase+clinical clinical+trials women+test
Vote for African Women Test Anti-HIV Gel in Phase 3 Clinical Trials:
|
Rating: 6.00 out of 3 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells